Answer
Liver enzymes (ALT and AST) and bilirubin should be monitored before starting tepotinib, every 2 weeks for the first 3 months, then monthly; dose adjustment is recommended if grade 3 or higher increases occur.
Sources for this answer
- Tepotinib 225 mg film-coated tabletsMerck · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked